Comparison of clinical outcomes of single-incision versus multi-port laparoscopic surgery for descending colon cancer: a propensity score-matched analysis

The clinical impact of single-incision laparoscopic surgery (SILS) for descending colon cancer (DCC) is unclear. The aim of this study was to evaluate the clinical outcomes of SILS for DCC compared with multi-port laparoscopic surgery (MPLS). We retrospectively analyzed 137 consecutive patients with...

Full description

Saved in:
Bibliographic Details
Published in:BMC gastroenterology 2022-12, Vol.22 (1), p.511-511, Article 511
Main Authors: Tei, Mitsuyoshi, Suzuki, Yozo, Sueda, Toshinori, Iwamoto, Kazuya, Naito, Atsushi, Nomura, Masatoshi, Yoshikawa, Yukihiro, Ohtsuka, Masahisa, Imasato, Mitsunobu, Mizushima, Tsunekazu, Akamatsu, Hiroki
Format: Article
Language:English
Subjects:
Abdominal surgery
Analysis
Cancer
Care and treatment
Clinical outcomes
Colectomy
Colon cancer
Colon, Descending - pathology
Colon, Descending - surgery
Colonic Neoplasms - pathology
Colonic Neoplasms - surgery
Colorectal cancer
DCC protein
Descending cancer
Diagnosis
Dissection
Gastroenterology
Hospitals
Humans
Laparoscopic surgery
Laparoscopy
Length of Stay
Lymph nodes
Lymphatic system
Medical prognosis
Morbidity
Nosocomial infections
Operative Time
Outcome
Pancreas
Patient outcomes
Patients
Propensity scores
Rectum
Relapse
Retrospective Studies
Single-incision laparoscopic surgery
Surgery
Treatment Outcome
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The clinical impact of single-incision laparoscopic surgery (SILS) for descending colon cancer (DCC) is unclear. The aim of this study was to evaluate the clinical outcomes of SILS for DCC compared with multi-port laparoscopic surgery (MPLS). We retrospectively analyzed 137 consecutive patients with stage I-III DCC who underwent SILS or MPLS at two high-volume multidisciplinary tertiary hospitals between April 2008 and December 2018, using propensity score-matched analysis. After propensity score-matching, we enrolled 88 patients (n = 44 in each group). SILS was successful in 97.7% of the matched cohort. Compared with the MPLS group, the SILS group showed significantly less blood loss and a greater number of harvested lymph nodes. Morbidity rates were similar between groups. Recurrence pattern did not differ between groups. No significant differences were found between groups in terms of 3-year disease-free and overall survivals. SILS appears safe and feasible and can provide satisfactory oncological outcomes for patients with DCC.
ISSN:1471-230X
1471-230X
DOI:10.1186/s12876-022-02597-z